Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  2. Prognostic Factors In Intrahepatic Cholangiocarcinoma - A Systematic Review.
  1. Home
  2. Prognostic Factors In Intrahepatic Cholangiocarcinoma - A Systematic Review.

Related Experiment Video

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K

Prognostic Factors in Intrahepatic Cholangiocarcinoma - A Systematic Review.

Anca Zgura, Catalin Savin, Luiza Tirca

    Chirurgia (Bucharest, Romania : 1990)
    |September 9, 2024

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Intrahepatic cholangiocarcinoma (ICCA) is a rare, aggressive cancer. Key prognostic factors influencing long-term outcomes include tumor characteristics and socioeconomic status, guiding treatment decisions.

    Keywords:
    chemotherapyintrahepaticcholangiocarcinomalymphaticnodemetastasisprognosisradicalresectionvascularinvasion

    More Related Videos

    A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
    12:24

    A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

    Published on: September 30, 2021

    5.1K
    Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
    09:19

    Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

    Published on: July 14, 2022

    3.3K

    Related Experiment Videos

    Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
    07:32

    Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

    Published on: April 12, 2024

    1.2K
    A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
    12:24

    A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

    Published on: September 30, 2021

    5.1K
    Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
    09:19

    Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

    Published on: July 14, 2022

    3.3K

    Area of Science:

    • Hepatobiliary surgery
    • Oncology
    • Gastroenterology

    Background:

    • Intrahepatic cholangiocarcinoma (ICCA) represents a rare and aggressive malignancy originating in the bile ducts.
    • Late diagnosis is common due to asymptomatic presentation, limiting surgical candidacy to 20-30% of patients.
    • The prognosis for ICCA is generally poor, necessitating identification of critical prognostic factors.

    Approach:

    • A systematic review of English-language articles published between January 2000 and December 2023 was conducted.
    • Databases searched included Cochrane Library, PubMed, Embase, MedLine, Web of Science, Elsevier, and Google Scholar.
    • The review focused on identifying prognostic factors impacting long-term patient outcomes.

    Key Points:

    • Socioeconomic factors significantly influence patient prognosis.
  • Tumor morphology, size, number, and extension are critical prognostic indicators.
  • Resection margins are a vital factor in determining long-term survival.
  • Conclusions:

    • Early recognition and identification of these prognostic factors are crucial.
    • Tailoring treatment strategies based on identified factors can improve long-term outcomes for ICCA patients.
    • Further research into optimizing management based on these prognosticators is warranted.